$27.99
-1.06-3.65%
最終更新: Oct 26, 8:48 AM
Benzinga
Benzinga
Benzinga
月曜日, 10 26
Benzinga
© 2026 Benzinga | All Rights Reserved
Vera Therapeutics (VERA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.59 | $-1.35 | $-1.30 | $-1.16 |
| Actual | $-1.52 | $-1.69 | $-1.39 | $-1.26 |
| Surprise | +4.40% | -25.2% | -6.92% | -8.62% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.63 | $-1.53 | $-1.35 | $-1.21 |
| Revenue | ||||
| Consensus | $3.5M | $16.9M | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-1.52 | $-1.59 | 4.40 % |
| Q1 | May 7, 2026 | $-1.69 | $-1.35 | -25.2 % |
| Q4 | Feb 26, 2026 | $-1.39 | $-1.30 | -6.92 % |
| Q3 | Nov 5, 2025 | $-1.26 | $-1.16 | -8.62 % |